Viaskin Peanut

DBV restructuring claims 200 jobs as it beats out a path toward peanut patch OK
Endpoints
Thu, 01/7/21 - 11:21 pm
DBV Technologies
peanut allergy
Viaskin Peanut
layoffs
Why DBV Technologies Stock Is Soaring Today
Motley Fool
Mon, 11/2/20 - 11:04 pm
DBV Technologies
Viaskin Peanut
peanut allergy
Europe
EMA
Viaskin™ Peanut’s Long-Term Phase III Updates and What the FDA Has to Say About Them
BioSpace
Fri, 08/14/20 - 11:03 am
DBV Technologies
Viaskin Peanut
peanut allergy
FDA
FDA turns back DBV Technologies’ peanut allergy patch, raising questions about its design
Fierce Biotech
Tue, 08/4/20 - 01:07 pm
DBV Technologies
FDA
Viaskin Peanut
With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash
Xconomy
Fri, 06/26/20 - 07:50 pm
DBV Technologies
FDA
peanut allergy
layoffs
Viaskin Peanut
A Tale of 2 Biotechs With Competing Peanut Allergy Treatments
Motley Fool
Thu, 04/16/20 - 11:43 pm
peanut allergy
Viaskin Peanut
DBV Technologies
Aimmune Therapeutics
Palforzia
In another win for rival Aimmune, FDA presses pause on DBV's peanut patch with additional questions
Endpoints
Tue, 03/17/20 - 12:01 pm
FDA
Aimmune
DBV Technologies
peanut allergy
Viaskin Peanut
DBV's peanut prevention patch approaches key stage of approval process
Endpoints
Fri, 02/21/20 - 10:27 am
DBV Technologies
peanut allergy
FDA
drug approvals
Viaskin Peanut
FDA decision nears on Aimmune's contested peanut allergy drug
BioPharma Dive
Fri, 01/24/20 - 12:07 pm
FDA
Aimmune
peanut allergy
Palforzia
DBV Technologies
Viaskin Peanut
DBV Technologies announces FDA acceptance of BLA filing for Viaskin Peanut to treat peanut allergy
Pharmaceutical Business Review
Mon, 10/7/19 - 10:58 am
Viaskin Peanut
DBV Technologies
FDA
peanut allergy
DBV Technologies Resubmits BLA for Peanut Allergy Treatment
BioSpace
Thu, 08/8/19 - 11:52 pm
DBV Technologies
FDA
peanut allergy
Viaskin Peanut
New peanut allergy therapies aren’t as effective — or nearly as inexpensive — as abstinence, says ICER
Endpoints
Thu, 07/11/19 - 12:03 pm
peanut allergy
Aimmune Therapeutics
DBV Technologies
ICER
AR101
Viaskin Peanut
DBV Rejoins Peanut Allergy Treatment Race, But Aimmune Takes the Lead
Xconomy
Thu, 02/14/19 - 12:08 am
DBV Technologies
Aimmune
peanut allergy
AR-101
Viaskin Peanut
DBV Technologies pulls peanut allergy treatment from FDA review
Stat
Thu, 12/20/18 - 12:13 am
DBV Technologies
peanut allergy
FDA
Viaskin Peanut
DBV climbs as peanut allergy safety data come in clean
Fierce Biotech
Mon, 11/20/17 - 09:53 am
peanut allergy
DBV Technologies
Viaskin Peanut
A new peanut allergy vaccine failed in a trial, but the company wants it approved anyway
Stat
Sun, 10/22/17 - 09:48 am
vaccines
food allergies
peanut allergy
DBV Technologies
Viaskin Peanut
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
DBV files to raise $245M to fuel race for peanut allergy market
Fierce Biotech
Thu, 07/16/15 - 06:32 pm
DBV Technologies
peanut allergy
Viaskin
Viaskin Peanut
DBV makes a beeline for Phase III as peanut allergy race hots up
Fierce Biotech
Thu, 06/25/15 - 09:29 am
DBV Technologies
vaccines
food allergies
peanut allergy
Viaskin Peanut